Fredenrich A, Giroux L M, Tremblay M, Krimbou L, Davignon J, Cohn J S
Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada.
J Lipid Res. 1997 Jul;38(7):1421-32.
In order to assess the relationship between plasma accumulation of triglyceride-rich lipoproteins (TRL) and lipoprotein levels of apoC-III and apoE, we have measured apoC-III and apoE in lipoproteins separated according to size (by automated gel filtration chromatography) from plasma of normolipidemic subjects (plasma triglyceride (TG): 0.84 +/- 0.10 mmol/l; mean +/- SE, n = 8), and from type III (n = 8) and type IV (n = 8) hyperlipoproteinemic patients, matched for plasma TG (5.76 +/- 0.62 v 5.55 +/- 0.45 mmol/l, resp.). Total plasma apoC-III concentration was similar in type III and type IV patients (33.1 +/- 3.4 v 37.6 +/- 4.4 mg/dl, respectively), but was significantly increased compared to normolipidemic controls (10.0 +/- 1.0 mg/dl, P < 0.001). TRL apoC-III was lower and high density lipoprotein (HDL) apoC-III was significantly higher in type III versus type IV subjects (14.8 +/- 3.2 vs. 22.8 +/- 3.0 mg/dl, P < 0.05; 8.3 +/- 1.0 vs. 5.2 +/- 0.5 mg/dl, P < 0.05). Plasma concentration of apoC-III in lipoproteins that eluted between TRL and HDL (intermediate-sized lipoproteins, ISL) was similar in the two hypertriglyceridemic groups (10.1 +/- 1.3 vs. 9.7 +/- 1.6 mg/dl), but was significantly higher (P< 0.05) than controls (2.2 +/- 0.3 mg/dl). TRL, ISL, and HDL apoE concentrations were significantly higher in type III versus type IV subjects (P < 0.05). All lipoprotein fractions in type III patients were characterized by lower apoC-III to apoE ratios. In contrast, the TRL apoC-III to apoE ratio of type IV patients was similar and the ISL apoC-III to apoE ratio was significantly higher, compared to normolipidemic individuals. These results indicate that compared to normolipidemic individuals, remnant-like lipoproteins in the ISL fraction of type IV patients are enriched in apoC-III relative to apoE, whereas those of type III patients are enriched in apoE relative to apoC-III.
为了评估富含甘油三酯的脂蛋白(TRL)的血浆蓄积与载脂蛋白C-III(apoC-III)和载脂蛋白E(apoE)的脂蛋白水平之间的关系,我们对血脂正常的受试者(血浆甘油三酯(TG):0.84±0.10 mmol/l;平均值±标准误,n = 8)、III型(n = 8)和IV型(n = 8)高脂血症患者血浆中按大小分离的脂蛋白(通过自动凝胶过滤色谱法)中的apoC-III和apoE进行了测量,这些患者的血浆TG相匹配(分别为5.76±0.62和5.55±0.45 mmol/l)。III型和IV型患者的血浆总apoC-III浓度相似(分别为33.1±3.4和37.6±4.4 mg/dl),但与血脂正常的对照组(10.0±1.0 mg/dl)相比显著升高(P < 0.001)。与IV型受试者相比,III型受试者的TRL apoC-III较低,高密度脂蛋白(HDL)apoC-III显著较高(14.8±3.2对22.8±3.0 mg/dl,P < 0.05;8.3±1.0对5.2±0.5 mg/dl,P < 0.05)。在两个高甘油三酯血症组中,洗脱于TRL和HDL之间的脂蛋白(中等大小脂蛋白,ISL)中的apoC-III血浆浓度相似(10.1±1.3对9.7±1.6 mg/dl),但显著高于对照组(2.2±0.3 mg/dl,P < 0.05)。与IV型受试者相比,III型受试者的TRL、ISL和HDL apoE浓度显著更高(P < 0.05)。III型患者的所有脂蛋白组分的特点是apoC-III与apoE的比值较低。相比之下,与血脂正常的个体相比,IV型患者的TRL apoC-III与apoE的比值相似,而ISL apoC-III与apoE的比值显著更高。这些结果表明,与血脂正常的个体相比,IV型患者ISL组分中的残留样脂蛋白相对于apoE富含apoC-III,而III型患者的残留样脂蛋白相对于apoC-III富含apoE。